loading
Sonnet Biotherapeutics Holdings Inc stock is traded at $3.5887, with a volume of 166.26K. It is down -12.14% in the last 24 hours and up +217.71% over the past month. Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.
See More
Previous Close:
$4.05
Open:
$3.92
24h Volume:
166.26K
Relative Volume:
0.05
Market Cap:
$11.33M
Revenue:
$129.20K
Net Income/Loss:
$-7.44M
P/E Ratio:
-0.3207
EPS:
-11.19
Net Cash Flow:
$-8.62M
1W Performance:
-30.90%
1M Performance:
+217.71%
6M Performance:
+110.56%
1Y Performance:
-48.06%
1-Day Range:
Value
$3.5501
$3.92
1-Week Range:
Value
$3.5501
$5.05
52-Week Range:
Value
$1.08
$19.30

Sonnet Biotherapeutics Holdings Inc Stock (SONN) Company Profile

Name
Name
Sonnet Biotherapeutics Holdings Inc
Name
Phone
609-375-2227
Name
Address
100 OVERLOOK CENTER, PRINCETON, NJ
Name
Employee
13
Name
Twitter
@SonnetBio
Name
Next Earnings Date
2024-08-12
Name
Latest SEC Filings
Name
SONN's Discussions on Twitter

Compare SONN with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
SONN
Sonnet Biotherapeutics Holdings Inc
3.58 24.99M 129.20K -7.44M -8.62M -11.19
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
463.64 120.60B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
553.33 60.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
326.35 42.87B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
593.62 36.23B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
301.15 31.54B 3.81B -644.79M -669.77M -6.24

Sonnet Biotherapeutics Holdings Inc Stock (SONN) Latest News

pulisher
Jul 28, 2025

What is the risk reward ratio of investing in Sonnet BioTherapeutics Holdings Inc. stockCapitalize on trading strategies that deliver - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Analyzing net buyer seller activity in Sonnet BioTherapeutics Holdings Inc.Insider Strategy for High Conviction Picks - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

Why is Sonnet BioTherapeutics Holdings Inc. stock attracting strong analyst attentionAchieve breakthrough profits with smart strategies - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What institutional investors are buying Sonnet BioTherapeutics Holdings Inc. stockCapitalize on momentum-driven investment opportunities - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What is the dividend policy of Sonnet BioTherapeutics Holdings Inc. stockUnlock exclusive stock market insights - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

Is Sonnet BioTherapeutics Holdings Inc. stock overvalued or undervaluedMaximize returns with strategic stock selection - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How strong is Sonnet BioTherapeutics Holdings Inc. company’s balance sheetUncover the best stocks for explosive growth - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Why Sonnet BioTherapeutics Holdings Inc. stock attracts strong analyst attentionHigh Return Potential - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

How Interest Rate Changes Impact Sonnet BioTherapeutics Holdings Inc. Stock PerformanceFree Access to Community - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

Top Risks to Consider Before Buying Sonnet BioTherapeutics Holdings Inc. StockFree Deep Market Trend Analysis - Newser

Jul 27, 2025
pulisher
Jul 25, 2025

What drives Sonnet BioTherapeutics Holdings Inc. stock priceSuperior profit margins - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Sonnet BioTherapeutics Holdings Inc. Stock Analysis and ForecastFree Stock Chart Pattern Guide - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Is Sonnet BioTherapeutics Holdings Inc. a good long term investmentFree Capital Efficiency Planning - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

How Sonnet BioTherapeutics Holdings Inc. stock performs during market volatilityFree Market Analysis Group - Newser

Jul 24, 2025
pulisher
Jul 23, 2025

What analysts say about Sonnet BioTherapeutics Holdings Inc. stockConsistently superior profits - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

Sonnet Announces the Passing of Founder and CEO Pankaj Mohan, Ph.D. - Yahoo.co

Jul 23, 2025
pulisher
Jul 19, 2025

Halper Sadeh investigates Sonnet BioTherapeutics, First Community Corp, Monogram Technologies mergers. - AInvest

Jul 19, 2025
pulisher
Jul 19, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SONN, FCCO, MGRM on Behalf of Shareholders - GlobeNewswire Inc.

Jul 19, 2025
pulisher
Jul 19, 2025

Biotech Minnow Sonnet Takes A Hard Turn Into Crypto - Finimize

Jul 19, 2025
pulisher
Jul 18, 2025

Sonnet BioTherapeutics Secures Funding to Meet Nasdaq Requirements - TipRanks

Jul 18, 2025
pulisher
Jul 18, 2025

Sonnet BioTherapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of SON-1010 for Advanced Solid Tumors - ACCESS Newswire

Jul 18, 2025
pulisher
Jul 17, 2025

12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

Jul 17, 2025
pulisher
Jul 17, 2025

Sonnet BioTherapeutics Bets Big on HYPE Token as Charts Signal 161% Rally Potential - CoinChapter

Jul 17, 2025
pulisher
Jul 17, 2025

Sonnet BioTherapeutics’ New Strategy with $888 Million Worth of Crypto Reserves! - Pintu

Jul 17, 2025
pulisher
Jul 16, 2025

Sonnet BioTherapeutics Launches $583 Million Crypto Treasury With HYPE Token - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

Hyperliquid Strategies Inc. plan for $583M treasury boosts HYPE price - Cointelegraph

Jul 16, 2025
pulisher
Jul 16, 2025

Sonnet BioTherapeutics Announces $888M Combination With Rorschach For HYPE Treasury - Tekedia

Jul 16, 2025

Sonnet Biotherapeutics Holdings Inc Stock (SONN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$22.69
price down icon 1.73%
$36.91
price down icon 0.55%
$102.76
price up icon 0.56%
$27.37
price down icon 0.04%
$111.86
price down icon 0.82%
biotechnology ONC
$301.40
price up icon 2.39%
Cap:     |  Volume (24h):